IL6 and acute respiratory distress syndrome: They found that MSCs could be stimulated by plasma of ARDS patient, which will lead to a possible phenotypic shift (decreased CD105 and CD90 expression) and the exacerbation of ARDS (increased levels of IL-6, fibronectin, and cytotoxicity).